What is the treatment for rheumatic fever?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Rheumatic Fever

Patients with acute rheumatic fever must receive a full 10-day course of penicillin to eradicate residual Group A Streptococcus (GAS), followed immediately by continuous antimicrobial prophylaxis with intramuscular benzathine penicillin G 1.2 million units every 4 weeks (or every 3 weeks in high-risk situations) to prevent recurrent attacks. 1, 2, 3

Acute Phase Treatment: Eradication of GAS

The initial treatment priority is complete eradication of streptococcal infection, even if throat culture is negative at diagnosis. 4, 1, 2

First-line antibiotic options:

  • Oral Penicillin V: 250 mg twice daily for 10 days (children <27 kg); 500 mg 2-3 times daily for 10 days (adolescents/adults or children ≥27 kg) 1, 2
  • Intramuscular Benzathine Penicillin G: Single injection of 600,000 units (<27 kg) or 1,200,000 units (≥27 kg) 2

For penicillin-allergic patients:

  • Erythromycin or first-generation cephalosporins (if no immediate-type hypersensitivity) 1, 3, 5

Important caveat: Treatment can be delayed up to 9 days after symptom onset and still effectively prevent rheumatic fever, allowing time for laboratory confirmation. 4, 2 However, once rheumatic fever is diagnosed, immediate treatment is essential. 4, 1

Secondary Prophylaxis: Prevention of Recurrence

Continuous antimicrobial prophylaxis is the cornerstone of rheumatic fever management and must be initiated immediately upon diagnosis. 4, 1, 3 This is critical because recurrent attacks worsen cardiac damage, and even asymptomatic GAS infections can trigger recurrence. 4, 3

Preferred regimen:

  • Benzathine Penicillin G: 1,200,000 units intramuscularly every 4 weeks 1, 3, 6
  • In high-risk populations or patients with recurrences despite adherence, consider every 3 weeks 3, 7

Evidence supporting intramuscular over oral: Intramuscular benzathine penicillin is approximately 10 times more effective than oral antibiotics at preventing rheumatic fever recurrence (0.1% vs 1% recurrence rate). 7, 8 This superiority is attributed to guaranteed compliance and sustained therapeutic levels. 8

Alternative for penicillin-allergic patients:

  • Erythromycin orally twice daily 5, 6, 9

Practical tip: Warming benzathine penicillin G to room temperature before administration reduces injection discomfort. 2

Duration of Prophylaxis

The duration depends on cardiac involvement and must be individualized based on specific criteria: 4, 1, 3

  • Rheumatic fever with carditis AND residual heart disease (persistent valvular disease): 10 years after last attack OR until age 40 (whichever is longer), sometimes lifelong 4, 1, 3
  • Rheumatic fever with carditis but NO residual heart disease: 10 years OR until age 21 (whichever is longer) 4, 1, 3
  • Rheumatic fever without carditis: 5 years OR until age 21 (whichever is longer) 4, 1, 3

Critical consideration: Prophylaxis should continue even after valve surgery, including prosthetic valve replacement. 3

Anti-Inflammatory Treatment for Symptom Relief

While antibiotics address the underlying infection and prevent recurrence, anti-inflammatory agents provide symptomatic relief but do NOT prevent rheumatic heart disease. 10

For severe inflammation or cardiac involvement:

  • Corticosteroids (prednisone 1-2 mg/kg/day for 1-2 weeks) may be considered 3
  • In severe cases with significant cardiac involvement, intravenous methylprednisolone (1000 mg/day initially) followed by oral prednisone 3

Special Populations and Situations

Family members: Streptococcal infections in family members of patients with current or previous rheumatic fever should be treated promptly to prevent transmission. 4, 3

Patients with rheumatic heart disease undergoing procedures: Those receiving benzathine penicillin prophylaxis still require amoxicillin prophylaxis before high-risk dental or surgical procedures. If recently treated with penicillin/amoxicillin or have immediate penicillin hypersensitivity, use clindamycin. 6

Obstetric considerations: Pregnant women should not receive erythromycin estolate due to risk of cholestatic hepatitis. 4

Common Pitfalls to Avoid

  • Inadequate duration of initial treatment: The full 10-day course is essential even if symptoms resolve earlier. 1, 2
  • Failure to initiate secondary prophylaxis immediately: At least one-third of rheumatic fever cases result from asymptomatic GAS infections, making continuous prophylaxis essential rather than episodic treatment. 1, 3
  • Premature discontinuation of prophylaxis: Even with optimal treatment, rheumatic fever can recur in susceptible individuals, necessitating adherence to duration guidelines. 1, 3
  • Using broad-spectrum antibiotics: These are more expensive and promote resistant flora compared to narrow-spectrum penicillin. 2
  • Assuming oral compliance: Intramuscular benzathine penicillin should be strongly considered for patients unlikely to complete oral courses, those with personal/family history of rheumatic fever, or those with environmental risk factors. 2

References

Guideline

Rheumatic Fever and Scarlet Fever Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Rheumatic Fever in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Acute Rheumatic Fever Mimicking Pericarditis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Penicillin for secondary prevention of rheumatic fever.

The Cochrane database of systematic reviews, 2002

Research

Rheumatic fever.

Current rheumatology reports, 2001

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.